National Institute of Standards & Technology 

 

Report of Investigation 
 
Reference Material 8321 
 
Peptide Mixture for Proteomics 

 
This  Reference  Material (RM)  is  intended  to  support  investigations  used  to  identify  peptides  in  complex  peptide 
mixtures such as those in mass spectrometry-based proteomics.  RM 8321 can be used to help assess the confidence 
of peptide identification within a laboratory or comparability between laboratories or among different measurement 
approaches.    RM 8321  can  also  be  used  in  the  development  and  validation  of  new  investigative  approaches  for 
identifying  peptides  in  complex  peptide  mixtures.    A  unit  of  RM 8321  consists  of  three  vials,  each  containing 
approximately  50 µL  of  frozen  aqueous  solution  containing  0.1 mL/L  formic  acid.    The  peptides  in  this  RM  are 
estimated to be in a concentration range of 0.1 pmol/µL to 10 pmol/µL. 
 
RM 8321 is an aqueous solution of approximately 440 synthetic peptides, present at a range of concentrations that 
span approximately three orders of magnitude.  RM 8321 was designed to provide a complex mixture of peptides for 
evaluating the performance of proteomics mass spectrometry instruments coupled to liquid chromatography (LC) [1].  
Peptides  were  chosen  to  cover  the  chromatographic  “space”  of  a  typical  reverse  phase  gradient  elution  analysis, 
offering a range of elution profiles.  The synthetic peptides in RM 8321 have the same amino acid sequence as tryptic 
peptides from 50 high abundance human plasma proteins that have been observed as proteotypic peptides through 
multiple published investigations by the proteomics community.  Proteotypic peptides are those peptides which are 
observed  repeatedly  by  mass  spectrometric-based  proteomics  investigations  by  different  investigators.    Therefore, 
proteotypic peptides are expected to be readily released from enzymatic digestions of the precursor protein, ionize 
well  by  electrospray  ionization,  generate  high  quality  tandem  mass  spectrometry (MS/MS)  spectra,  and  are  stable 
during the processes of sample preparation and analysis. 
 
Reference Values:  A NIST reference value represents the best estimation of the true value based upon the available 
data [2].  Table 1 lists a set of heuristic rules  which describe the confidence of peptide identification in RM 8321.  
Table 2 lists the peptides present, grouped by confidence level, as determined by two types of LC-MS/MS analyses 
and comparison to mass spectral libraries [3]. 
 
Expiration  of  Reference  Values:    RM 8321  is  valid,  within  the  specified  confidence  levels,  until  05 June 2020, 
provided the RM is handled and stored in accordance with the instructions given in this report (see “Instructions for 
Storage and Use”).  This report is nullified if the RM is damaged, contaminated, or otherwise modified. 
 
Maintenance of RM:  NIST will monitor this RM over the period of its validity.  If substantive technical changes 
occur that affect the value assignment before the expiration of this report, NIST will notify the purchaser.  Registration 
(see attached sheet or register online) will facilitate notification. 
 
Overall direction and coordination of technical  measurements leading to peptide identification  were performed by 
D.M. Bunk of the NIST Biomolecular Measurement Division. 
 
Analyses were performed by A.S. Beasley, M. Lowenthal, and D.M. Bunk of the NIST Biomolecular Measurement 
Division. 
 
Support aspects involved in the issuance of this RM were coordinated through the NIST Office of Reference Materials. 
 
 
 
 
 
 
 
Gaithersburg, MD 20899  
Report Issue Date:  28 December 2015 

Michael J. Tarlov, Chief 
Biomolecular Measurement Division 

Robert L. Watters, Jr., Director 
Office of Reference Materials 

peptide  identification

libraries 

Page 1 of 5 

  

RM 8321 

Reference  Values:    Table 1  defines  the  corresponding  confidence  levels  of  peptide  identification  in  RM 8321.  
Table 2  identifies  the  peptide  content,  grouped  by  confidence  level,  based  on  both  the  data  dependent 
acquisition (DDA) and dynamic multiple reaction monitoring (dMRM) analyses. 
 

Rules 
Table 1.  Definitions of Heuristic Rules 
 
  

Confidence Level 

Heuristic Definition 

  

High Confidence 

Peptides  listed  were  observed  in  more  than  90 %  of  all  laboratory  investigations 
(including technical and process replicate analyses). 

Confident 

  

 
    

Peptides listed were observed in more than 50 % and less than 90 % of all laboratory 
investigations. 

  

Peptides listed were observed in less than 50 % of all laboratory investigations. 

Low Confidence 

less  than 

50 

  

Table 2.  Reference Peptide Content of RM 8321 

  

 
 

High Confidence: 
AATVGSLAGQPLQER 
ADLFYDVEALDLESPK 
AEDHFSVIDFNQNIR 
AEFAEVSK 
AFQPFFVELTMPYSVIR 
AGALNSNDAFVLK 
AGDFLEANYMNLQR 
AGKEPGLQIWR 
AHVSFKPTVAQQR 
AHYGGFTVQNEANK 
AIEDYINEFSVR 
AIGYLNTGYQR 
AKPALEDLR 
ALDLINKR 
ALLVGEHLNIIVTPK 
ALMDETMK 
ALTDMPQMR 
ALVQQMEQLR 
ALYLQYTDETFR 
AMAVEDIISR 
APNHAVVTR 
AQLVDMK 
AQRQVVAGLNFR 
ASEAEDASLLSFMQGYMK 
ASSIIDELFQDR 
ASSIIDELFQDRFFTR 
ASTPNGYDNGIIWATWK 
ATEHLSTLSEK 
ATFQTPDFIVPLTDLR 
ATGVLYDYVNK 
ATVVYQGER 
AVMDDFAAFVEK 
AVSMPSFSILGSDVR 
AYKSELEEQLTPVAEETR 
DALSSVQESQVAQQAR 
DAQYAPGYDKVK 
DDEEFIESNK 
DDNPNLPR 
DFHINLFQVLPWLK 
DFVQPPTK 
DGAGDVAFVK 
DGNTLTYYR 
DHAVDLIQK 

HLSLLTTLSNR 
HLVPGAPFLLQALVR 
HPDYSVVLLLR 
HQLYIDETVNSNIPTNLR 
HQTVPQNTGGKNPDPWAK 
HSIFTPETNPR 
HSTIFENLANK 
HTLNQIDEVK 
HTSVQTTSSGSGPFTDVR 
HVVPNEVVVQR 
HYEGSTVPEK 
HYQINQQWER 
IADAHLDR 
IADNKQSSFK 
IAFSATR 
IAQWQSFQLEGGLK 
IDTQDIEASHYR 
IEGNLIFDPNNYLPK 
IHWESASLLR 
IIRSSEDPNEDIVER 
IIVPLNNR 
IKVLNQELR 
ILGGHLDAK 
IPIEDGSGEVVLSR 
IPLDLVPK 
ISASAEELR 
ISEGLPALEFPNEK 
ITENDIQIALDDAK 
ITPNLAEFAFSLYR 
IVSSAMEPDR 
IYGNQDTSSQLKK 
IYHSHIDAPK 
IYISGMAPRPSLAK 
IYLYTLNDNAR 
KAMAVEDIISR 
KATVVYQGER 
KDNEQHVFK 
KELSSFIDK 
KFPSGTFEQVSQLVK 
KGEWVALNPLR 
KLSSWVLLMK 
KLVPFATELHER 
KLWAYLTINQLLAER 

SDVVYTDWKKDK 
SEETKENEGFTVTAEGK 
SELEEQLTPVAEETR 
SELTQQLNALFQDK 
SFFSFLGEAFDGAR 
SGAQATWTELPWPHEK 
SGFPQVSMFFTHTFPK 
SGKDPNHFRPAGLPEK 
SGVQQLIQYYQDQK 
SHALQLNNR 
SIEVFGQFNGK 
SKEFQLFSSPHGK 
SKEQLTPLIK 
SLAELGGHLDQQVEEFRR 
SLAPYAQDTQEK 
SLHTLFGDK 
SPELQAEAK 
SPELQAEAKSYFEK 
SSALDMENFR 
SSEDPNEDIVER 
SSLSVPYVIVPLK 
SSNLIILEEHLK 
SVLGQLGITK 
SVNDLYIQK 
SVSDGIAALDLNAVANK 
SVVDENFSWYLEDNIK 
SYFEKSKEQLTPLIK 
SYFPESWLWEVHLVPR 
SYTITGLQPGTDYK 
TAAQNLYEK 
TAAQNLYEKTYLPAVDEK 
TAGWNIPMGLLYNK 
TDAPDLPEENQAR 
TEDTIFLR 
TEGDGVYTLNDK 
TEHPFTVEEFVLPK 
TEHYEEQIEAFK 
TELRPGETLNVNFLLR 
TEVNVLPGAK 
TGAQELLR 
TGLQEVEVK 
THLAPYSDELR 
THLPEVFLSK 

RM 8321 

Page 2 of 5 

High Confidence (continued): 
DINYVNPVIK 
DISEVVTPR 
DKVNSFFSTFK 
DLATVYVDVLK 
DLKVEDIPLAR 
DLMEKVKSPELQAEAK 
DMYSFLEDMGLK 
DRVVEESELAR 
DSGRDYVSQFEGSALGK 
DSQEEEKTEALTSAK 
DSQEEEKTEALTSAKR 
DTVIKPLLVEPEGLEK 
DTVQIHDITGK 
DVVLFEK 
DWHGVPGQVDAAMAGR 
DYWSTVK 
EAQLPVIENK 
EDLIWELLNQAQEHFGK 
EDTPNSVWEPAK 
EELLPAQDIK 
EESPLLIGQQSTVSDVPR 
EFQLFSSPHGK 
ELDESLQVAER 
ELSSFIDK 
ELSYYSLEDLNNK 
EMSGSPASGIPVK 
ENADSLQASLRPHADELK 
ENISDPTSPLR 
EPAHLMSLFGGKPMIIYK 
EPTMYVGSTSVQTSR 
EQLGPVTQEFWDNLEK 
ESDTSYVSLK 
ESYSGVTLDPR 
ETAVDGELVVLYDVK 
EVAFDLEIPK 
EVDLKDYEDQQK 
EWFWDLATGTMK 
EYVLPSFEVIVEPTEK 
FAFNLYR 
FEDGVLDPDYPR 
FFHKNEIWYR 
FKDLGEENFK 
FLATTPNSLLVSWQPPR 
FMETVAEK 
FNAVLTNPQGDYDTSTGK 
FPEVDVLTK 
FPSGTFEQVSQLVK 
FPVEMTHNHNFR 
FQNSAILTIQPK 
FSVPAGIVIPSFQALTAR 
FSVVYAK 
FSYSKNETYQLFLSYSSK 
FSYSSGHVHLSSENK 
FTNIGPDTMR 
FTVDRPFLFLIYEHR 
FVTWIEGVMR 
FYNQVSTPLLR 
GAYPLSIEPIGVR 
GDKVWVYPPEKK 
GDSGGAFAVQDPNDK 
GDSGGPLIVHK 

KSASDLTWDNLK 
KTLLSNLEEAKK 
KVEQAVETEPEPELR 
KVPQVSTPTLVEVSR 
KWQEEMELYR 
KYFIDFVAR 
KYNSQNQSNNQFVLYR 
LANLTQGEDQYYLR 
LAVYQAGAR 
LDAQASFLPK 
LDELRDEGK 
LDEVKEQVAEVR 
LDGKFSVVYAK 
LDGSVDFK 
LDGSVDFKK 
LEEQAQQIR 
LFDSDPITVTVPVEVSRK 
LGPHAGDVEGHLSFLEK 
LGPLVEQGR 
LGQYASPTAK 
LGVRPSQGGEAPR 
LHEAFSPVSYQHDLALLR 
LHIMAGR 
LKEEIGKELEELR 
LKNSLFEYQK 
LKSWFEPLVEDMQR 
LLDNWDSVTSTFSK 
LLIYAVLPTGDVIGDSAK 
LNAENNATFYFK 
LPPNVVEESAR 
LQAEAFQAR 
LQGTLPVEAR 
LQHLENELTHDIITK 
LRDLYSK 
LREQLGPVTQEFWDNLEK 
LRTEGDGVYTLNDKK 
LSINTHPSQKPLSITVR 
LSNENHGIAQR 
LSPIYNLVPVK 
LTIGEGQQHHLGGAK 
LVAYYTLIGASGQR 
LVDKFLEDVKK 
LVNEVTEFAK 
LVTDLTK 
LWAYLTIQELLAK 
MATTMIQSK 
MGPTELLIEMEDWK 
MGPTELLIEMEDWKGDK 
MKGLIDEVNQDFTNR 
MKPVPDLVPGNFK 
MVETTAYALLTSLNLK 
MYLGYEYVTAIR 
NANFKFTDHLK 
NFPSPVDAAFR 
NGNMAGISDQR 
NHMQYEIVIK 
NKPGVYTDVAYYLAWIR 
NNKDSHSLTTNIMEILR 
NPANPVQR 
NPNLPPETVDSLK 
NSLFEYQK 

THLPEVFLSKVLEPTLK 
TILGTMPAFEVSLQALQK 
TLEAQLTPR 
TLLPVSKPEIR 
TLLSNLEEAK 
TMEQFTIHLTVNPQSK 
TMTIHNGMFFSTYDR 
TNFDNDIALVR 
TPSAAYLWVGTGASEAEK 
TSNFNAAISLK 
TTIEKPVWLGFLGPIIK 
TTNIQGINLLFSSR 
TVGSDTFYSFK 
TVIGPDGHK 
TVMVNIENPEGIPVK 
TWRNDLISATK 
TYETTLEK 
TYLPAVDEK 
TYLPAVDEKLR 
TYLPAVDEKLRDLYSK 
TYMLAFDVNDEK 
TYNVLDMK 
VDKDNEDFQESNR 
VDVIPVNLPGEHGQR 
VEDPESTLFGSVIR 
VFDEFKPLVEEPQNLIK 
VFSNGADLSGVTEEAPLK 
VGDTLNLNLR 
VGFYESDVMGR 
VGPEADKYR 
VGYVSGWGR 
VIGNMGQTMEQLTPELK 
VKDISEVVTPR 
VKDLATVYVDVLK 
VKSPELQAEAK 
VKSPELQAEAKSYFEK 
VLEPTLK 
VLNQELR 
VLSLAQEQVGGSPEK 
VLVDHFGYTK 
VMDKYTFELSR 
VNKDDEEFIESNK 
VPEARPNSMVVEHPEFLK 
VPGLYYFTYHASSR 
VPGTSTSATLTGLTR 
VPLLLSEPINIIDALEMR 
VPQVSTPTLVEVSR 
VQHIQLLQK 
VQPYLDDFQK 
VRGGEGTGYFVDFSVR 
VSFLSALEEYTK 
VTIMWTPPESAVTGYR 
VTWAPPPSIDLTNFLVR 
VVGGLVALR 
VVLHPNYSQVDIGLIK 
VWVYPPEKK 
VWVYPPEKK 
VYKPSAGNNSLYR 
VYSLNDDLKPAK 
WFYIASAFR 
WKNFPSPVDAAFR 

RM 8321 

Page 3 of 5 

High Confidence (continued): 
GDSGGPLIVHKR 
GDSPASSKPISINYR 
GDVAFVK 
GETHEQVHSILHFK 
GEVQAMLGQSTEELR 
GEVQAMLGQSTEELRVR 
GEWVALNPLR 
GFEPTLEALFGK 
GFSLDEATNLNGGLLR 
GGEGTGYFVDFSVR 
GGETAQSADPQWEQLNNK 
GGYTLVSGYPK 
GHLFLQTDQPIYNPGQR 
GHMLENHVER 
GKWERPFEVK 
GSESGIFTNTK 
GSFEFPVGDAVSK 
GSPAINVAVHVFR 
GWVTDGFSSLK 
GWVTDGFSSLKDYWSTVK 
GYSIFSYATK 
HGGLYHENMR 
HLEVDVWVIEPQGLR 
 
Confident: 
AHVDALR 
ALFVSEEEKK 
ALVEGVDQLFTDYQIK 
AYYENSPQQVFSTEFEVK 
DGYLFQLLR 
DIFTGLIGPMK 
DLEIEVVLFHPNYNINGK 
DNDGWLTSDPR 
DNENVVNEYSSELEK 
DNEQHVFK 
DRLDEVKEQVAEVR 
DSAHGFLK 
DSGFQMNQLR 
DTEEEDFHVDQVTTVK 
DYVSQFEGSALGK 
ERGHMLENHVER 
ESLSSYWESAK 
EYHFGQAVR 
 
Low Confidence: 
DVVLTTTFVDDIK 
EDFTSLSLVLYSR 

NWGLSVYADKPETTK 
NWIQYK 
NYNLVESLK 
PALPAGTEDTAKEDAANR 
PLVEEPQNLIK 
PNSMVVEHPEFLK 
PPEIAHGYVEHSVR 
PYTFHSHGITYYK 
QFSFPLSSEPFQGSYK 
QGHNSVFLIK 
RHPDYSVVLLLR 
RHPYFYAPELLFFAK 
RLDGSVDFK 
RLDGSVDFKK 
RLEVDIDIK 
RPYFPVAVGK 
RQSEDSTFYLGER 
RRDGYLFQLLR 
RSFFSFLGEAFDGAR 
RTHLPEVFLSK 
RVDTVDPPYPR 
RVEPYGENFNK 
RYIETDPANR 
 

FNKPFVFLMIEQNTK 
GDKVWVYPPEK 
GETHEQVHSILHFK 
GSPAINVAVHVFRK 
GSWVNKFPVEMTHNHNFR 
HGTDDGVVWMNWK 
HTSLGPLEAK 
IPKSDVVYTDWKK 
IPTTFENGR 
IQPSGGTNINEALLR 
KGEWVALNPLRK 
KTLLSNLEEAK 
LDDDLEHQGGHVLDHGHK 
LEQGENVFLQATDK 
LLPHANEVSQK 
LSPLGEEMR 
LSSPAVITDK 
MLTPEHVFIHPGWK 
 

WLPSSSPVTGYR 
WQEEMELYR 
WSRPQAPITGYR 
WYEIEKIPTTFENGR 
YEASILTHDSSIR 
YEFLNGR 
YEITTIHNLFR 
YFIDFVAR 
YGLVTYATYPK 
YGMVAQVTQTLK 
YKEENDDFASFRVDR 
YLGEEYVK 
YLQEIYNSNNQK 
YLQEIYNSNNQKIVNLK 
YLYEIAR 
YNPVVIDFEMQPIHEVLR 
YQISVNK 
YTFELSR 
YVGGQEHFAHLLILR 
YVLPNFEVK 
YVNKEIQNAVNGVK 
YYTYLIMNK 
 
 

NRDVVLTTTFVDDIK 
RQDNEILIFWSK 
RTHLPEVFLSKVLEPTLK 
SDVVYTDWK 
SDVVYTDWKK 
SIEVFGQFNGKR 
SKEQLTPLIKK 
SWFEPLVEDMQR 
SYFEKSKEQLTPLIKK 
TLLSNLEEAKK 
TVIGPDGHKEVTK 
VDTVDPPYPR 
VQFELHYQEVK 
VTFQLTYEEVLK 
WDPYKQGFGNVATNTDGK 
WFYIASAFRNEEYNK 
YVGGQEHFAHLLILRDTK 
 
 

 

 

PVWLGFLGPIIK 
SNLDEDIIAEENIVSR 

TEGDGVYTLNNEK 
VELEDWNGR 

RM 8321 

Page 4 of 5 

in 

INSTRUCTIONS FOR STORAGE AND USE 
 
Handling:  RM 8321 is a frozen aqueous solution containing approximately 440 synthetic peptides in 0.1 mL/L formic 
g  the  material’s  handling  and  use. 
acid.  Normal caution and care should be exercised during the material’s handling and use. 
 
Storage:  The peptide mixture solution is shipped frozen (on dry ice) and, upon receipt, should be stored frozen until 
ready for use.  A freezer temperature of –20 °C is acceptable for storage for up to one week.  If a longer storage time 
is  anticipated,  the  material  should  be  stored  at  or  below  –60 °C.    The  RM  should  not  be  exposed  to  sunlight  or 
tion  or 
ultraviolet radiation.  Storage of thawed material at room or refrigerator temperatures may result in degradation or 
modification of constituent peptides. 
 
Use:  Vials of the RM to be analyzed should be removed from the freezer and allowed to stand at room temperature 
(20 °C to 25 °C) until thawed.  After the material is thawed, it should be used immediately.  The material should be 
mixed briefly with a vortex mixer before aliquots are withdrawn.  
 
PREPARATION AND ANALYSIS(1) 
 
Material Acquisition and Preparation:  The synthetic peptides used in the preparation of the RM were obtained 
from  GenScript  USA  Inc.  (Piscataway, NJ).    Aqueous  solutions  of  each  synthetic  peptide  were  prepared  and 
characterized by LC-MS using a time-of-flight mass analyzer and by LC-MS/MS using an ion trap mass analyzer.  
Each synthetic peptide was assessed for identify, purity, and its chromatographic and mass spectrometric behavior.  
Based on this assessment, solutions of 440 synthetic peptides were blended together to produce the peptide mixture in 
RM 8321.  Two additional LC-MS/MS analyses were performed on the RM to confirm the presence of each expected 
peptide.  Using DDA, the RM was analyzed using reversed-phase LC coupled to a LTQ XL (Thermo Scientific) ion 
trap mass spectrometer.  The data from the DDA  was analyzed using theoretical fragmentation libraries of tryptic 
peptides from all human proteins and a library containing only the peptides used to prepare the RM.  The data from 
the ion trap analysis was also searched using a mass spectral library containing only spectra from the peptides used to 
prepare the RM.  In addition to the ion trap analysis, the presence of peptides in the RM was also confirmed through 
analysis  using  reversed-phase  LC  coupled  to  a  model 6460  (Agilent  Technologies)  triple  quadrupole  mass 
spectrometer operated in dMRM mode.  The dMRM method monitored three different MRM transitions for each of 
the expected peptides in the RM.   
 
peptide  content  of 
Homogeneity Analysis:  The homogeneity was assessed at the time the analyses for the reference peptide content of 
the RM were performed.  A stratified random sampling plan was devised to test for homogeneity across the production 
lot.  The results indicated that no appreciable vial-to-vial differences were detected.  
 

y 

REFERENCES 

 
[1]  Rudnick, P.A.;  Clauser, K.R.;  Kilpatrick, L.E.;  Tchekhovskoi, D.V.;  Neta, P.;  Blonder, N.;  Billheimer, D.D.; 
Blackman, R.K.; Bunk, D.M.; Cardasis, H.L.; Ham, A.J.; Jaffe, J.D.; Kinsinger, C.R.; Mesri, M.; Neubert, T.A.; 
Schilling,  B.;  Tabb, D.L.;  Tegeler, T.J.;  Vega-Montoto, L.;  Variyath, A.M.;  Wang, M.;  Wang, P.; 
Whiteaker, J.R.;  Zimmerman, L.J.;  Carr, S.A.;  Fisher, S.J.;  Gibson, B.W.;  Paulovich, A.G.;  Regnier, F.E.; 
Rodriguez, H.;  Spiegelman, C.;  Tempst, P.;  Liebler, D.C.;  Stein, S.E.;  Performance  Metrics  for  Liquid 
Chromatography-Tandem Mass Spectrometry Systems in Proteomics Analyses; Mol. Cell Proteomics, Vol. 9(2), 
pp. 225–241 (2010). 

[2]  May, W.;  Parris, R.;  Beck II, C.;  Fassett, J.;  Greenberg, R.;  Guenther, F.;  Kramer, G.;  Wise, S.;  Gills, T.; 
Colbert, J.; Gettings, R.; MacDonald, B.; Definition of Terms and Modes Used at NIST for Value Assignment of 
Reference  Materials  for  Chemical  Measurements;  NIST  Special  Publication  260-136  (2000);  available  at 
http://www.nist.gov/srm/upload/SP260-136.PDF (accessed Dec 2015). 

[3]  Stein, S.; Mass Spectral Reference Libraries: An Ever-Expanding Resource for Chemical Identification; Anal. 

Chem., Vol. 84(17), pp. 7274–7282 (2012). 

84( 

 
 
 
 
This  can  be
Users  of  this  RM  should  ensure  that  the  Report  of  Investigation  in  their  possession  is  current.    This  can  be 
(301) 948-3730; 
telephone 
accomplished  by  contacting 
e-mail srminfo@nist.gov; or via the Internet at http://www.nist.gov/srm. 

igation  in  their  possession  is  current. 

the  SRM  Program: 

(301) 975-2200; 

fax 

 

                                                 

(1)  Certain  commercial  equipment,  instruments,  or  materials  are  identified  in  this  report  to  adequately  specify  the 
experimental procedure.  Such identification does not imply recommendation or endorsement by the National Institute of Standards 
and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. 
RM 8321 

Page 5 of 5 

